A big article talks about how some things people buy and sell in the U.S. are going up and down in price. Some parts of these things, called stocks, are doing well and others are not. One company named Centene did really good with their money and more than people thought they would. Read from source...

- The article title is misleading and does not reflect the main content of the article. It implies that crude oil gains are related to Centene sales, which is not supported by any evidence or analysis in the text. A better title would be "U.S. Stocks Mixed as Crude Oil Gains 1% and Centene Sales Top Views".
- The article does not provide any context or explanation for why crude oil prices are rising or how they affect the market. It simply states the fact without any analysis or implications for investors or consumers. A more informative paragraph would include some background information on the factors driving crude oil prices, such as supply and demand, geopolitical tensions, or economic indicators.
- The article focuses too much on Centene's sales performance and guidance, without considering other aspects of the company's operations, strategy, or outlook. It also does not compare Centene to its peers or competitors in the health care sector, nor does it mention any potential risks or challenges that the company may face in the future. A more balanced article would include some additional information on Centene's growth drivers, margins, profitability, valuation, and industry trends.
- The article uses vague and subjective terms to describe Centene's results, such as "better-than-expected" and "top views". These phrases do not provide any objective or meaningful information to the readers, nor do they support any arguments or conclusions. A more accurate article would use specific and quantitative data to illustrate Centene's performance, such as revenue, earnings, EPS, margin, or return on investment metrics.
- The article ends abruptly with an incomplete sentence that leaves the readers hanging. It does not provide any closure or summary of the main points or takeaways from the article. A more appropriate conclusion would restate the main thesis or argument of the article, and provide some insights or recommendations for investors or readers who are interested in the topic.